— Partnership with GSK


Development of influenza vaccines


Learn more

— Latest Technologies’ news



April 18, 2017

Valneva Announces Signing of a New EB66® Commercial License with Bavarian Nordic


Learn more

— IC31®


a novel
adjuvant



Learn more

— Services



valneva’s development
and testing services




Learn more

— Partnering


Team up with valneva
to develop vaccines



Learn more

Please update your browser...